
The true zzso of cancer chemotherapy have to be zzso of survival, zzso of symptoms, or improvement of quality of life in cancer patients, while the response rate is considered to be a surrogate zzso When conducting a phase III trial, not only the response rate but also data on zzso in the phase II study should be taken into zzso New response evaluation criteria and various objective markers in analyzing survival have been developed zzso Our data on chemotherapy for gastrointestinal zzso reveal correlations between zzso cases and survival zzso among zzso cancer patients treated with zzso and between zzso and survival zzso in gastric cancer patients treated with zzso A review of the literature might reveal a correlation between response and survival zzso in zzso chemotherapy patients, though our data did not support such a zzso At present, it is necessary to recognize that zzso should be based on the results of zzso phase III trials with large sample sizes and good quality assurance other than the response rates in phase II zzso 

